Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexandra K Gold, M.A.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F31MH116557 (GOLD, ALEXANDRA KATE) Jan 1, 2019 - Dec 31, 2021
    NIH
    Impaired Risk Avoidance in Bipolar Disorder and Substance Use Disorders
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gold AK, Albury EA, Stromberg A, French NJ, Peters AT, Katz D, Nierenberg AA, Sylvia LG. Cigarette smokers with a mood symptom history enrolled in a physical activity trial. Bipolar Disord. 2021 Oct 04. PMID: 34606143.
    Citations:    Fields:    
  2. Hoyt DL, Hiserodt M, Gold AK, Milligan MA, Otto MW. Is Ignorance Bliss? Examining the Effect of News Media Exposure on Anxiety and Depression During the COVID-19 Pandemic. J Nerv Ment Dis. 2021 Sep 13. PMID: 34524229.
    Citations:    Fields:    
  3. Milligan MA, Hoyt DL, Gold AK, Hiserodt M, Otto MW. COVID-19 vaccine acceptance: influential roles of political party and religiosity. Psychol Health Med. 2021 Aug 18; 1-11. PMID: 34407721.
    Citations:    Fields:    
  4. Mayorga NA, Smit T, Garey L, Gold AK, Otto MW, Zvolensky MJ. Evaluating the Interactive Effect of COVID-19 Worry and Loneliness on Mental Health Among Young Adults. Cognit Ther Res. 2021 Jul 25; 1-9. PMID: 34334844.
    Citations:    
  5. Sylvia LG, Faulkner M, Rakhilin M, Amado S, Gold AK, Albury EA, Dinerman JG, Dohse H, Tovey R, Turner JA, Schopfer DW, Pletcher MJ, Nierenberg AA. An online intervention for increasing physical activity in individuals with mood disorders at risk for cardiovascular disease: Design considerations. J Affect Disord. 2021 08 01; 291:102-109. PMID: 34029880.
    Citations:    Fields:    Translation:Humans
  6. Gold AK, Otto MW, Hoyt DL, Garey L, Smit T, Zvolensky M. Do Pain-Related Anxiety and Difficulties With Emotion Regulation Impact Abstinence Expectancies or Motivation to Quit E-Cigarette Use? J Stud Alcohol Drugs. 2021 05; 82(3):414-421. PMID: 34100710.
    Citations:    Fields:    
  7. Sylvia LG, Janos JA, Pegg SL, Montana RE, Gold AK, Bianchi M, Nierenberg AA. Pilot Study of a Brief Sleep Intervention for Suicidal Ideation in Bipolar Disorder. J Psychiatr Pract. 2021 03 05; 27(2):109-114. PMID: 33656816.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  8. Gold AK, Hoyt DL, Milligan M, Hiserodt ML, Samora J, Leyro TM, Zvolensky MJ, Otto MW. The role of fear of COVID-19 in motivation to quit smoking and reductions in cigarette smoking: a preliminary investigation of at-risk cigarette smokers. Cogn Behav Ther. 2021 May-Jul; 50(4):295-304. PMID: 33605833.
    Citations: 3     Fields:    Translation:Humans
  9. Stathopoulou G, Gold AK, Hoyt DL, Milligan M, Hearon BA, Otto MW. Does anxiety sensitivity predict addiction severity in opioid use disorder? Addict Behav. 2021 01; 112:106644. PMID: 32987306.
    Citations: 1     Fields:    Translation:Humans
  10. Gold AK, Sylvia LG, Nierenberg AA, Ostacher MJ. Preliminary findings on topiramate for addressing health behaviors in comorbid bipolar disorder and alcohol use disorder. Psychiatry Res. 2020 07; 289:113037. PMID: 32447093.
    Citations:    Fields:    
  11. Gold AK, Otto MW, Sylvia LG. Bipolar disorder as a condition of heterogeneity: Embracing an adaptive psychosocial approach. Bipolar Disord. 2020 06; 22(4):416-417. PMID: 32145140.
    Citations:    Fields:    Translation:Humans
  12. Gold AK, Ornelas AC, Cirillo P, Caldieraro MA, Nardi AE, Nierenberg AA, Kinrys G. Clinical applications of transcranial magnetic stimulation in bipolar disorder. Brain Behav. 2019 10; 9(10):e01419. PMID: 31566935.
    Citations: 4     Fields:    Translation:Humans
  13. Chentsova-Dutton YE, Gold A, Gomes A, Ryder AG. Feelings in the body: Cultural variations in the somatic concomitants of affective experience. Emotion. 2020 Dec; 20(8):1490-1494. PMID: 31524420.
    Citations:    Fields:    Translation:Humans
  14. Cirillo P, Gold AK, Nardi AE, Ornelas AC, Nierenberg AA, Camprodon J, Kinrys G. Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis. Brain Behav. 2019 06; 9(6):e01284. PMID: 31066227.
    Citations: 11     Fields:    Translation:Humans
  15. Gold AK, Kinrys G. Treating Circadian Rhythm Disruption in Bipolar Disorder. Curr Psychiatry Rep. 2019 03 02; 21(3):14. PMID: 30826893.
    Citations: 5     Fields:    Translation:Humans
  16. Gold AK, Stathopoulou G, Otto MW. Emotion regulation and motives for illicit drug use in opioid-dependent patients. Cogn Behav Ther. 2020 01; 49(1):74-80. PMID: 30760111.
    Citations: 2     Fields:    Translation:Humans
  17. Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019 03 01; 246:126-131. PMID: 30580198.
    Citations: 1     Fields:    Translation:Humans
  18. Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M. Tachyphylaxis in major depressive disorder: A review of the current state of research. J Affect Disord. 2019 02 15; 245:488-497. PMID: 30439676.
    Citations: 5     Fields:    Translation:Humans
  19. Gold AK, Toomey R. The role of cerebellar impairment in emotion processing: a case study. Cerebellum Ataxias. 2018; 5:11. PMID: 30345063.
    Citations:    
  20. Sylvia LG, Hearing CM, Montana RE, Gold AK, Walsh SL, Janos JA, Tovey RE, Deckersbach T, Nierenberg AA. MoodNetwork: An Innovative Approach to Patient-centered Research. Med Care. 2018 10; 56 Suppl 10 Suppl 1:S48-S52. PMID: 30074951.
    Citations: 4     Fields:    Translation:Humans
  21. Gold AK, Peters AT, Otto MW, Sylvia LG, Magalhaes PVDS, Berk M, Dougherty DD, Miklowitz DJ, Frank E, Nierenberg AA, Deckersbach T. The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial. Aust N Z J Psychiatry. 2018 09; 52(9):847-855. PMID: 30047784.
    Citations: 1     Fields:    Translation:Humans
  22. Gold AK, Otto MW, Deckersbach T, Sylvia LG, Nierenberg AA, Kinrys G. Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. Am J Addict. 2018 04; 27(3):188-201. PMID: 29596721.
    Citations: 5     Fields:    Translation:Humans
  23. Kinrys G, Gold AK, Worthington JJ, Nierenberg AA. Medication disposal practices: Increasing patient and clinician education on safe methods. J Int Med Res. 2018 Mar; 46(3):927-939. PMID: 29322845.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  24. Arbetter DF, Jain P, Yee MK, Michalak N, Hernandez AF, Hull RD, Goldhaber SZ, Harrington RA, Gold A, Cohen AT, Gibson CM. Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy. Pharm Stat. 2017 11; 16(6):445-450. PMID: 28840662.
    Citations: 2     Fields:    Translation:Humans
  25. Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG. Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. J Affect Disord. 2018 01 01; 225:775-777. PMID: 28826887.
    Citations:    Fields:    
  26. Gibson CM, Korjian S, Chi G, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Lopes RD, Gold A, Cohen AT, Harrington RA. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. J Am Heart Assoc. 2017 Jul 11; 6(7). PMID: 28698258.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  27. Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017 Jun; 1(1):e56-e65. PMID: 31249911.
    Citations: 23     
  28. Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG. Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. J Affect Disord. 2017 08 01; 217:183-189. PMID: 28411507.
    Citations: 2     Fields:    Translation:Humans
  29. Gibson CM, Halaby R, Korjian S, Daaboul Y, Arbetter DF, Yee MK, Goldhaber SZ, Hull R, Hernandez AF, Lu SP, Bandman O, Leeds JM, Gold A, Harrington RA, Cohen AT. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J. 2017 Mar; 185:93-100. PMID: 28267480.
    Citations: 17     Fields:    Translation:Humans
  30. Gibson CM, Chi G, Halaby R, Korjian S, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Gold A, Bandman O, Harrington RA, Cohen AT. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). Circulation. 2017 02 14; 135(7):648-655. PMID: 27881569.
    Citations: 19     Fields:    Translation:Humans
  31. Gold AK, Montana RE, Sylvia LG, Nierenberg AA, Deckersbach T. Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders. Curr Behav Neurosci Rep. 2016 Dec; 3(4):340-349. PMID: 27917364.
    Citations: 1     
  32. Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA. Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. J Affect Disord. 2016 Nov 15; 205:159-164. PMID: 27449548.
    Citations:    Fields:    Translation:Humans
  33. Gold AK, Sylvia LG. The role of sleep in bipolar disorder. Nat Sci Sleep. 2016; 8:207-14. PMID: 27418862.
    Citations: 12     
  34. Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, Nierenberg AA, Miklowitz DJ. A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD. J Affect Disord. 2016 Oct; 203:152-157. PMID: 27289316.
    Citations: 3     Fields:    Translation:Humans
  35. Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG. Empirically supported psychosocial interventions for bipolar disorder: Current state of the research. J Affect Disord. 2016 Sep 01; 201:203-14. PMID: 27243619.
    Citations: 19     Fields:    Translation:Humans
  36. Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ. A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. Am J Addict. 2016 Mar; 25(2):94-8. PMID: 26894822.
    Citations: 8     Fields:    Translation:Humans
  37. Reilly-Harrington NA, Shelton RC, Kamali M, Rabideau DJ, Shesler LW, Trivedi MH, McElroy SL, Sylvia LG, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Bobo WV, Deckersbach T, Tohen M, McInnis MG, Kocsis JH, Gold AK, Singh V, Finkelstein DM, Kinrys G, Nierenberg AA. A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. J Affect Disord. 2016 Mar 01; 192:212-8. PMID: 26748736.
    Citations: 3     Fields:    Translation:Humans
  38. Ostacher MJ, Nierenberg AA, Rabideau D, Reilly-Harrington NA, Sylvia LG, Gold AK, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Iosifescu DV, Thase ME, Leon AC, Trivedi MH. A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR). J Psychiatr Res. 2015 Dec; 71:126-33. PMID: 26476489.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gold's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (117)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.